Skip to main content
Fig. 1 | Journal of Cardiovascular Magnetic Resonance

Fig. 1

From: Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease

Fig. 1

Meta-model lifetime discounted incremental net monetary benefit results (compared to ‘No Imaging’); higher incremental net monetary benefit indicates better cost effectiveness profile. Net Monetary Benefit (NMB) is a single metric that monetizes QALYs (using willingness-to-pay of $100,000/QALY) and subtracts costs. CMR cardiovascular magnetic resonance, CCT coronary computed tomography angiography, ICA invasive coronary angiography; Genders et al. [20]; Ge et al. [13]

Back to article page